ARTICLE | Clinical News
CelTx regulatory update
January 4, 2010 8:00 AM UTC
Organogenesis filed a PMA with FDA for CelTx to regenerate oral soft tissue in patients with gingival recession. The product is a cellular construct comprised of human fibroblasts, keratinocytes and e...